跳至主要内容
临床试验/ACTRN12607000635460
ACTRN12607000635460已完成未知

THE USE OF MELANOCYTE/KERATINOCYTE CO-SUSPENSION FOR THE RE-PIGMENTATION OF AMELANOTIC PATCHES IN VITILIGO

Royal Adelaide Hospital0 个研究点目标入组 15 人开始时间: 2007年12月12日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients must have established vitiligo of any duration (an idea of the efficacy of the treatment in early, active vitiligo must be gained).
  • Patients must be > 18 years old
  • Patients must be able and willing to provide consent to all aspects of the study following verbal and written explanation of the study by the investigating clinician.
  • Patients must have a leukodermic patch for study, which is outside cosmetically sensitive areas such as the face ie low back, medial thigh, medial arm etc.
  • Patients must have no documented previous reaction to local anaesthetic agents.

排除标准

  • Any contraindication to surgery/anaesthesia
  • Any failure of consent process

研究者

相似试验